Introducing the Influenza Panel, a new offering from our pathological services designed to diagnose five critical viral infections using advanced PCR (Polymerase Chain Reaction) technology. This panel includes tests for Influenza A, Influenza B, H1N1, H3N2, and SARS-CoVid 19, providing a comprehensive diagnostic approach for viral illnesses that commonly affect the respiratory system. By detecting the presence of these viruses at the genetic level, the Influenza Panel offers precise and reliable results, ensuring quick and accurate diagnosis.

The PCR method of diagnosis is a significant advancement over conventional testing methods like antigen tests or viral cultures. Unlike traditional methods, PCR amplifies the genetic material of the virus, allowing for detection even at low viral loads, which is crucial in the early stages of infection. PCR tests are highly sensitive and specific, minimizing the chances of false negatives or positives. This allows healthcare providers to identify infections accurately, leading to better treatment decisions. Additionally, PCR testing provides faster results, enabling timely intervention and reducing the spread of infectious diseases. With the Influenza Panel, individuals can confidently know their viral health status and receive appropriate care.